शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSERoopa Industries Ltd· Pharmaceuticals & BiotechnologyHighNeutral
Announced Fri, 14 Nov, 2025 · 18:52 IST

Board Meeting Outcome and submission of Unaudited Financial Results for the quarter and half year ended 30 September 2025

EBITDA margin compressionEmphasis of matterDebt to equity above the thresholdResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-3.3%Reaction day
₹49.00
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.6%-3.9% vs market
Pharmaceuticals peers, median of 157sector+0.1%-3.4% vs sector

On the reaction day the stock moved 3.9 pts less than Nifty Microcap 250 and 3.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-3.3+0.6-3.9+0.1-3.4
Next day
-3.1-0.2-2.8-0.7-2.4
2d
-0.1-0.4+0.3-1.2+1.1
3d
+2.0-0.7+2.7-0.9+2.9
4d
+2.4-2.2+4.6-2.0+4.4
5d
-5.9-2.8-3.1-3.1-2.8
1w
-1.8-1.4-0.4-2.2+0.4
15d
-15.4-7.0-8.4-4.7-10.7
1m
-6.3-6.1-0.2-5.0-1.3
2m
-4.1-9.2+5.1-7.8+3.7
3m
-0.8-6.8+6.0-9.7+8.9
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Roopa Industries reported standalone unaudited results for Q2 FY26 with revenue from operations of Rs. 2,874.48 lakhs, up about 12% YoY from Rs. 2,561.24 lakhs. H1 FY26 revenue rose around 6% to Rs. 6,381.75 lakhs. Profitability, however, weakened — Q2 PAT fell to Rs. 46.42 lakhs (from Rs. 58.27 lakhs) and H1 PAT slipped to Rs. 74.76 lakhs (from Rs. 85.64 lakhs), with PBT margins compressing on higher material and finance costs. The auditor separately drew attention to a fire accident at the Patancheru plant on 3 November 2025 that destroyed some inventory; the company is assessing the loss for an insurance claim. Cash and bank balances plunged from Rs. 338.20 lakhs to Rs. 45.65 lakhs, while total borrowings of Rs. 3,608.56 lakhs against equity of Rs. 1,824.25 lakhs imply a debt-to-equity ratio close to 2x.

Likely market impact

Topline growth is encouraging but shrinking profits and thin operating margins are a concern for shareholders. The Patancheru fire adds an additional overhang until the insurance recovery is quantified, and the elevated debt with a sharply reduced cash buffer warrants close monitoring.